Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
An interesting point Alarno...shame the same care to détail was not forthcoming when they took two thirds of our shares. 1.2p is embarrassing by the way.
don't think so
Good time for Goodbody to acquire 18,248,107 shares through the NCIB. Anyone would think it was contrived????
i totally agree alarno.
Everything is set up. So, they need to prove that the blood testing business is working and generating significant revenue. I would be more reassured if they already have more than 400 pharmacies. But sometimes you are not in the driver seat and need to wait for decisions on the other side.
I agree. Henry was either a mistake or the fall guy who got £750k for his troubles. Did not go downhill tho. Generating revenues of £17m from covid when you are a cbd company is sheer brilliance. Producing hand sanitiser during lockdown was inventive. Moving into bloods and well being at a time when the NHS is buckling is forward thinking. Whats not to like, other than the share price?
Geremy made an error appointing Henry Lees Buckley...it went down hill after that...
Geremy definitely did not take his eye off the ball. He has adapted to market conditions and regulations imposed on the sale of cbd and covid. I strongly believe that this business will come good. Geremy is brilliant at seeking out new opportunities. I appreciate the fact that he is embarrassed by the share price..
got it guys. You are all longer invested than me. looks like that they will shift the Q&A to the AGM. :(
Geremy has been trading for 4 years. He started as Sativa Investments, he was in prime position with first mover advantage and took his eye off the ball. Various name changes to company and changes of CEO is not great. Just like the SP!
Spot on Alarno. That's exactly what happened. However, even if I wanted to top up and lower my average, which is ridiculous by the way, it would cost me a fortune to do it! Which is my ongoing point, I don't understand why the company haven't grasped this?!
@alarno
thanks for sharing these details
LeBadinho, Goodbody bought Stillcanna at great cost to shareholders at the time. We gave 3 of our shares for one of Stillcanna's. I saw my money shrink by two thirds straight after the deal. I had close to 1m shares at the time. I then bought more to lower my average. The share price has since halved. Yes, it risky because if they do it again I will have thrown good money after bad. Goodbody got the cash from Stillcanna that they wanted and we paid the price for it. Very honest interview from Geremy. He has told long suffering shareholders to hang in there. So, I will.....I have faith. Has to be seen as an inventment, not a punt
'The Share Price is embarrassing', haha. Damn right it is. Onwards and upwards...!!!!
@Skycity1
When did Geremy buy Stillcanna? 4 years ago? pretty new information for me.
There are also regulations for doing advertising about CBD in the UK. Some companies do not care about those regulation. GDBY complies as long as they have no official authorisation from the FSA.
How the hell is Geremy going sell CBD if he doesn't advertise? Yet to see an advert in the last 4 years. Also, GBDY social media channels are awful...
i don't think that there will be one. It needs the right price target and to be honest I don't think that Geremy Thomas will sell that company for less than 100mio pounds.
If that will happen the SP will go up automatically ;D
what do you mean by that? can you explain it? because there is no big strategic change at all since Geremy took over.
Sativa bougth a CBD company (Stillcanna) during a time where it was not clear how the British govermental instituations will come up with CBD legalization. During that time they secured the whole business by diversification.
They added revenues and cash by doing some adjustments on their whole company strategy. So nothing has changed dramatically. CBD business is still there and will grow if the market regualtions are clear. And the health care business will help to get revenues in the deposit during that time.
The danger here is another reverse takeover whereby our current stake gets diluted further. Its risky
Definitely not worth a punt. The CEO is erratic and constantly changing strategy....
well, I'm a german shareholder and already set some additional buys on the german side. But to be honest, you should have a look on the SP for the next week. If it decreases more, I will add some more.
CSE de-listing needed to be done. WOuld have been better do it with the takeover in 2020/beginning of 2021 but it was necessary to open news doors to institutional investors in the UK/Europe.
Anyone else thinking of topping up to lower their average, or is a further drop on the cards?
to add something more on that:
I think most of the canadian guys didn't get the point that they will still be able to trade their shares. Maybe it's some kind of bad game that canadian brokers telling their clients that they will not be able anymore to trade after de-listing. but that is not true at all.
so hopefully an interview and some detailed information about future trading possibilities for canadian shareholders will cover it.
He guys,
what is wrong to makes such a huge step for the company by getting delisted in Canada where is no company business done!! Most of German investors don'T want to invest in Canadian small caps anymore so european institutional investors do.
Okay, it's pretty ugly wants currently going on in Canada but to be honest it was a necessary step for the future success of the company in Europe. Hopefully there will be an interview wih Marc or Geremy to explain it in more detail and make the current shareholders more comfortable with that major decision.
And I totally agree with alarno. Even if the Clinic network rollout is lacking a bit behind and the FSA novel food list currently not showd a big impact the revenue and cash is there to bring the company in the right position for the future starting right now.
Best place for them. The board have acknowledged that things are going to take some time to get to where they need to be. Clinic openings have been painfully slow. If blood tests don't take off we will be struggling. Looking at Yooma figures for cbd are not encouraging either. Market cap tho is not a reflection of our assets. We are worth alot more than that